Physician profile
Mohsen Ehsan
NPI 1669560215
$2,321.67
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,322.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $634.59 | 2019 | |
| Abbvie INC. | $317.23 | 2019 | |
| Ucb, INC. | $166.10 | 2019 | |
| Novartis Pharmaceuticals Corporation | $147.12 | 2019 | |
| Mallinckrodt Enterprises LLC | $137.73 | 2019 | |
| Lilly USA, LLC | $130.19 | 2019 | |
| Radius Health, INC. | $116.09 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $97.55 | 2019 | |
| Janssen Biotech, INC. | $76.47 | 2019 | |
| Celgene Corporation | $64.59 | 2019 | |
| Pfizer INC. | $59.89 | 2019 | |
| Genentech USA, INC. | $57.95 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $54.15 | 2019 | |
| Alexion Pharmaceuticals, INC. | $48.36 | 2019 | |
| Glaxosmithkline, LLC. | $39.69 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $39.39 | 2019 | |
| Genzyme Corporation | $23.21 | 2019 | |
| Shire North American Group INC | $20.05 | 2019 | |
| Antares Pharma, INC. | $17.79 | 2019 | |
| Pacira Therapeutics, INC. | $14.38 | 2019 | |
| Medexus Pharma, INC. | $12.49 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $12.48 | 2019 | |
| Fidia Pharma USA INC. | $11.75 | 2019 | |
| Zyla Life Sciences, INC. | $11.41 | 2019 | |
| Hikma Pharmaceuticals USA | $11.02 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohsen Ehsan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.